Position in FATE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$110,311
+$97,464 QoQ
Shares Held
40,856
+281.6% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#73
of 156 holders
Holding Since
Dec 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AXQ CAPITAL, LP holds $45,364,119 across 106 Biotechnology names. FATE ranks #79 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
91,437 | $3,566,957 | |
| 2 | INSM |
INSMED Inc
|
22,813 | $2,432,322 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
30,831 | $2,413,142 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,952 | $1,840,690 | |
| 5 | MRNA |
Moderna, Inc.
|
22,477 | $1,574,064 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
39,712 | $1,405,407 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,797 | $1,389,353 | |
| 8 | SMMT |
Summit Therapeutics Inc.
|
93,624 | $1,364,101 |
All Filings in FATE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,311 | 40,856 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $12,847 | 10,706 | Shares | Sole | 2026-05-13 | |
| 2024-03-31 | $149,736 | 20,400 | Shares | Sole | 2024-05-14 | |
| 2023-03-31 | $90,994 | 15,964 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $687,522 | 68,139 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||